Defence Therapeutics stock forecast
Defence Therapeutics (DTC) Stock Forecast & Price Target
DTC Analyst Ratings
There are no analyst ratings in the last 3 months.
DTC Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.21→EUR 0.17 | sell | -22.85%Downside | Reiterated | 11/03/26 | ||
| Google Biotechnology | TipRanks - Google | EUR 0.21→EUR 0.17 | sell | -23.14%Downside | Reiterated | 11/03/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | EUR 0.20→EUR 0.16 | sell | -28.02%Downside | Reiterated | 11/03/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.21→EUR 0.17 | hold | -20.85%Downside | Reiterated | 11/03/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.21→EUR 0.17 | sell | -23.14%Downside | Reiterated | 11/03/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.21→EUR 0.17 | hold | -21.42%Downside | Reiterated | 11/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | SellReiteratedEUR 0.21→EUR 0.17 | 11/03/26 | -22.85%Downside | ||
| Google BiotechnologyTipRanks - Google | SellReiteratedEUR 0.21→EUR 0.17 | 11/03/26 | -23.14%Downside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | SellReiteratedEUR 0.20→EUR 0.16 | 11/03/26 | -28.02%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiteratedEUR 0.21→EUR 0.17 | 11/03/26 | -20.85%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | SellReiteratedEUR 0.21→EUR 0.17 | 11/03/26 | -23.14%Downside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiteratedEUR 0.21→EUR 0.17 | 11/03/26 | -21.42%Downside |
Best Analysts Covering Defence Therapeutics
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.00% per trade.
DTC Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, DTC has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DTC average Analyst price target in the past 3 months is ―.
DTC Financial Forecast
DTC Sales Forecast
Next quarter’s sales forecast for DTC is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
